How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018
News
25 October 2018

How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018

Steering group co-chair Professor Jane Anderson (Consultant Physician, Homerton University Hospital, London) will present findings from HIV Outcomes' assessment of how effectively health systems are monitoring HIV-associated comorbidities at this year's HIV Drug Therapy conference in Glasgow on 28-31 October 2018.

While HIV has become a chronic condition, evidence suggests that there are a growing number of people living with HIV suffering from non-AIDS-defining comorbidities. Using current global and European frameworks, the HIV Outcomes abstract assesses whether existing monitoring frameworks sufficiently enable European countries to observe and understand the comorbidities that impact on the health and well-being of people living with HIV.

The abstract is taken from research work being undertaken by the HIV Outcomes study group.

More updates All

28 February 2023
2022 has been a challenging year, as the COVID-19 pandemic, the war in Ukraine and the mpox outbreak have had an impact on the health-related quality of life (HRQoL) of people living with HIV. In the words of our Ambassador, Vytenis ...
More
17 February 2023
HIV Outcomes welcomes the European Commission's upcoming Communication on a comprehensive approach to mental health. With the breakthroughs in antiretroviral therapy (ART) and the increased life expectancy of people living ...
More
29 November 2022
With widespread availability of anti-retroviral therapy, life expectancy among people with HIV is approaching that of the general population. Yet this does not always mean years spent in good health. People with HIV are at higher risk of developing a ...
More
Filters
This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.